RT Journal Article
SR Electronic
T1 765 NG-350A, a tumor-selective anti-CD40 agonist expressing therapeutic, gemcitabine/nab-paclitaxel and ipilimumab for untreated metastatic pancreatic adenocarcinoma: cohort C of the REVOLUTION trial
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A860
OP A860
DO 10.1136/jitc-2023-SITC2023.0765
VO 11
IS Suppl 1
A1 O’Reilly, Eileen M
A1 O’Hara, Mark H
A1 Fisher, George
A1 Wolff, Robert A
A1 Wainberg, Zev A
A1 Ko, Andrew H
A1 Arnott, Jamie
A1 Cabanski, Christopher R
A1 Upadhaya, Samik
A1 Saez-Ibanez, Ana Rosa
A1 Campbell, Jay
A1 Francis, James
A1 Rosen, Oliver
A1 Bucktrout, Samantha
A1 Boffo, Silvia
A1 Dugan, Ute
A1 O’Donnell-Tormey, Jill
A1 Vonderheide, Robert H
A1 Khalil, Danny
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A860.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.